Evaluation of the efficacy of Nd:YAG laser in the treatment of 80 patients with oral mucosal venous malformation

doi:10.19439/j.sjos.2023.02.010

Abstract

Abstract: PURPOSE: To evaluate the efficacy of Nd:YAG laser treatment for venous malformations. METHODS: Eighty patients with oral mucosal venous malformations underwent one or more Nd:YAG laser treatments, and photographs of the lesions before and after laser treatment were collected and compared, patients' satisfaction were assessed using visual analog scale (VAS). SPSS 22.0 software package was used for data analysis. RESULTS: A total of 58 cases were cured in 80 patients, 21 cases showed remarkable improvement. Nine patients(11.25%) experienced adverse effects after laser therapy, including atrophic scars in 2 patients, oral mucosal ulcers in 4 patients, transient hyperpigmentation in 2 patients, and transient hypopigmentation in 1 patient, which met the expected response to effective therapy, and the follow-up results showed that most patients achieved maximum satisfaction values. CONCLUSIONS: Nd:YAG laser is an effective and safe treatment for oral mucosal venous malformation with definite efficacy and few side effects, which is worthy of popularization and application.

Key words: Nd:YAG laser, Venous malformation, Oral mucosa

CLC Number:

R782

ZHAO Ning, SUN Li-ying, LI Yun-ling, MA Chuan, CAI Zhen, ZHU Chao. Evaluation of the efficacy of Nd:YAG laser in the treatment of 80 patients with oral mucosal venous malformation[J]. Shanghai Journal of Stomatology, 2023, 32(2): 166-171.

References

[1] Merrow AC, Gupta A, Patel MN, et al.2014 revised classification of vascular lesions from the International Society for the Study of Vascular Anomalies: radiologic-pathologic update[J]. Radiographics, 2016, 36(5): 1494-1516.
[2] Migliari D, Vieira RR, Nakajima EK, et al.Successful management of lip and oral venous varices by photocoagulation with Nd:YAG laser[J]. J Contemp Dent Pract, 2015, 16(9): 723-726.
[3] John HE, Phen HS, Mahaffey PJ.Treatment of venous lesions of the lips and perioral area with a long-pulsed Nd:YAG laser[J]. Br J Oral Maxillofac Surg, 2016, 54(4): 376-378.
[4] Manna S, Meyer A, Shigematsu T, et al.Management of a laryngeal venous malformation with Nd:YAG laser and bleomycin sclerotherapy[J]. Laryngoscope, 2020, 130(9): 2199-2201.
[5] Horbach SE, Lokhorst MM, Saeed P, et al.Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents[J]. J Plast Reconstr Aesthet Surg, 2016, 69(3): 295-304.
[6] Azma E, Razaghi M.Laser treatment of oral and maxillofacial hemangioma[J]. J Lasers Med Sci, 2018, 9(4): 228-232.
[7] Iannetti G, Torroni A, Chiummariello S, et al.Clinical and morphological characteristics of head-facial haemangiomas[J]. Head Face Med, 2007, 3: 12-21.
[8] Buckmiller LM, Richter GT, Suen JY.Diagnosis and management of hemangiomas and vascular malformations of the head and neck[J]. Oral Dis, 2010, 16(5): 405-418.
[9] Storch CH, Hoeger PH.Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action[J]. Br J Dermatol, 2010, 163(2): 269-274.
[10] Haggstrom AN, Drolet BA, Baselga E, et al.Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment[J]. Pediatrics, 2006, 118(3): 882-887.
[11] Frieden IJ, Haggstrom AN, Drolet BA, et al.Infantile hemangiomas: current knowledge, future directions. proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA[J]. Pediatr Dermatol, 2005, 22(5): 383-406.
[12] Suarez-Sharp S, Li M, Duan J, et al.Regulatory experience with in vivo in vitro correlations (IVIVC) in new drug applications[J]. AAPS J, 2016, 18(6): 1379-1390.
[13] Shen L, Zhou G, Zhao J, et al.Pulsed dye laser therapy for infantile hemangiomas: a systemic review and meta-analysis[J]. QJM, 2015, 108(6): 473-480.
[14] 周国瑜,张志愿,张陈平,等. 口腔颌面部静脉畸形及血管瘤的激光治疗研究[J]. 中华口腔医学杂志, 2005, 40(3): 200-202.
[15] Nammour S, El Mobadder M, Namour M, et al.Aesthetic treatment outcomes of capillary hemangioma, venous lake, and venous malformation of the lip using different surgical procedures and laser wavelengths (Nd:YAG, Er,Cr:YSGG, CO₂, and Diode 980 nm)[J]. Int J Environ Res Public Health, 2020, 17(22): 8665-8683.
[16] Srinivas CR, Kumaresan M.Lasers for vascular lesions: standard guidelines of care[J]. Indian J Dermatol Venereol Leprol, 2011, 77(3): 349-368.
[17] Sethuraman G, Yenamandra VK, Gupta V.Management of infantile hemangiomas: current trends[J]. J Cutan Aesthet Surg, 2014, 7(2): 75-85.
[18] Cannarozzo G, Negosanti F, Sannino M, et al.Q-switched Nd:YAG laser for cosmetic tattoo removal[J]. Dermatol Ther, 2019, 32(5): e13042.
[19] Bacci C, Sacchetto L, Zanette G, et al.Diode laser to treat small oral vascular malformations: a prospective case series study[J]. Lasers Surg Med, 2018, 50(2): 111-116.
[20] Asai T, Suzuki H, Takeuchi J, et al.Effectiveness of photocoagulation using an Nd:YAG laser for the treatment of vascular malformations in the oral region[J]. Photomed Laser Surg, 2014, 32(2): 75-80.
[21] Mlacker S, Shah VV, Aldahan AS, et al.Laser and light-based treatments of venous lakes: a literature review[J]. Lasers Med Sci, 2016, 31(7): 1511-1519.
[22] 郑家伟,周琴,王延安,等. 口腔颌面部血管瘤治疗指南[J]. 中国口腔颌面外科杂志, 2011, 9(1): 61-67.
[23] Khandpur S, Sharma VK.Assessment of efficacy of the 595-nm pulsed dye laser in the treatment of facial port-wine stains in Indian patients[J]. Dermatol Surg, 2016, 42(6): 717-726.
[24] Costa Mendes L, Laurencin-Dalicieux S, Paul C, et al.Vascular Nd:YAG laser: a therapeutic alternative for large venous lakes of the oral mucosa[J]. J Eur Acad Dermatol Venereol, 2020, 34(4): e164-e165.
[25] Spradley TP, Johnson AB, Wright HD, et al.Gentle ND:YAG laser therapy in the treatment of cutaneous venous malformations[J]. Facial Plast Surg Aesthet Med, 2021, 23(4): 289-293.
[26] 秦中平,邰茂众,李克雷,等. 激光在婴幼儿血管瘤治疗中的作用评价[J]. 中国口腔颌面外科杂志, 2013, 11(6): 443-446.
[27] Davidson AJ, Disma N, de Graaff JC, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial[J]. Lancet, 2016, 387(10015): 239-250.
[28] Bi M, Li D, Chen Z, et al.Foam sclerotherapy compared with liquid sclerotherapy for the treatment of lower extremity varicose veins: a protocol for systematic review and meta analysis[J]. Medicine (Baltimore), 2020, 99(22): e20332.
[29] Weitz-Tuoretmaa A, Keski-Nisula L, Rautio R, et al.Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol[J]. Acta Radiol, 2018, 59(8): 946-952.
[30] Yang X, Chen H, Gu H, et al.Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations[J]. J Vasc Surg Venous Lymphat Disord, 2020, 8(6): 1066-1073.
[31] Hou F, Chen J, Xia M, et al.Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - a retrospective cohort study from a single tertiary medical center[J]. Medicine (Baltimore), 2020, 99(9): e18839.
[32] 吴海威,于淼,郑家伟.口腔颌面部静脉畸形诊治:经验与进展[J]. 中国口腔颌面外科杂志, 2021, 19(2): 186-192.
[33] 雷红召,邱海霞. 激光治疗血管瘤和血管畸形的研究进展[J]. 中国激光医学杂志, 2012, 21(1): 52-59.